LYMPHODEPLETION

This adverse event was reported 34 times

LYMPHODEPLETION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LIFILEUCEL 1 0.0035
1 SILTUXIMAB 1 0.0015
2 MOGAMULIZUMAB-KPKC 2 0.0015
3 ALDESLEUKIN 1 0.0008
4 TALQUETAMAB-TGVS 1 0.0007
5 SELUMETINIB 1 0.0006
6 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
7 TECLISTAMAB-CQYV 1 0.0004
8 CARFILZOMIB 10 0.0004
9 BELANTAMAB MAFODOTIN 1 0.0003
See all drugs enriched for association with LYMPHODEPLETION